NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock. The number of shares ... read more

The Board of Elan Corporation, plc (NYSE : ELN) (Elan) notes today’s announcement regarding the revised offer by Echo Pharma Acquisition Limited (“Royalty Pharma”) to acquire Elan's shares under Rule 2.5 of the Irish Takeover Rules. The Board of ... read more

Acurian, Inc., a leading, full-service provider of global patient enrollment and retention solutions, announced today it has agreed to a two-year partnership with the Society for Clinical Research Sites (SCRS), based in Rockville, MD. The SCRS is the first ... read more

Today, PatientsLikeMe announces an open call for medical researchers to be among the first pilot users of its Open Research Exchange™ (ORE) platform (www.openresearchexchange.com). ORE puts patients at the center of the clinical research process and allows researchers to pilot, deploy, share, and validate new ways ... read more

The COPD Foundation will host COPD8USA, a multi-disciplinary, Continuing Medical Education (CME) conference, June 14-15, 2013, Hilton Chicago, 720 S. Michigan Ave., Chicago, Ill. The event provides crucial clinical and scientific knowledge for primary care physicians, pulmonologists, registered nurses, physician ... read more

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, PhD will present at the USC Minisymposium: Musculoskeletal Development and Repair conference at the Keck School of Medicine, ... read more

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: ^NBI) effective prior to today’s market open. ... read more

CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announced the issuance of its annual Letter to Stockholders from President and CEO Steven A. Kriegsman. The Letter provides an overview of the Company’s business plan and is ... read more

OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today announced that OvaScience Co-Founder Jonathan L. Tilly, Ph.D., has been named to The Boston Globe’s 2013 “The Innovators” feature. ... read more

Thermo Fisher Scientific Inc., the world leader in serving science, has launched the new Thermo Scientific small benchtop centrifuge, delivering, in a compact footprint, the flexibility to adapt to evolving clinical and research needs alike, including clinical chemistry, cell culture, microbiology and hematology. Featuring innovative Thermo ... read more

To commemorate National Cancer Research Month, a team of scientists from GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are joined together in a technology “relay race” against cancer. They collectively are driving technologies across the entire continuum of cancer ... read more

AB SCIEX, a global leader in analytical technologies, today announced the launch of the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe. Meeting regulatory requirements to obtain the CE-IVDD mark for the new AB SCIEX API ... read more

R-Tech Ueno, Ltd. (JASDAQ:4573): This is to announce start of the patient enrollment of the first stage of a Phase I/II clinical study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101(Note ... read more

For the fifth consecutive year, Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) has been named to the Globe 100 annual list, the Boston Globe’s annual ranking of the 100 top-performing public companies headquartered in Massachusetts. Cubist was ranked number six overall and was named the top performing biotech ... read more

May 17, 2013 – Top winner Ionut Budisteanu, 19, of Romania (center) with second-place winners Eesha Khare, 18, of Saratoga, Calif. (left) and Henry Lin, 17, of Shreveport, La. celebrate their awards at the Intel International Science and Engineering Fair, the world’s largest high school science ... read more

Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, has been contacted by the New York Stock Exchange regarding today’s trading in the Company’s common stock. It is the Company’s policy not to comment on trading activity. About ... read more

GlycoMimetics, Inc. announced today that the Tech Council of Maryland (TCM) named Rachel K. King, GlycoMimetics Chief Executive Officer, as the winner of its 2013 Executive of the Year award. Ms. King was honored last night at the TCM's 25th Annual Tech ... read more

Santarus, Inc. (NASDAQ: SNTS) today announced that additional data from two pivotal clinical studies with UCERIS® (budesonide) extended release tablets will be featured in two poster presentations at the Digestive Disease Week® (DDW®) Meeting being held in Orlando, Fla. from ... read more

InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that the Company will be conducting a webcast of the Annual Shareholders Meeting scheduled for Thursday, May 23, 2013 at 10:00 a.m. ... read more

May 16, 2013 – Madelyn Lucas, 14, from Farmington, N.M. explained her research project on probiotics’ affect on the digestive system to an eager group of middle schoolers at the Intel International Science and Engineering Fair, the world’s largest high school science research competition. More than ... read more